IQVIA SOLUTIONS B.V. -  

Ranking results:

Past rankings:

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2023 0 6.997.523 178.750 1
2022 0 6.953.004 610.858 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ACADEMISCH ZIEKENHUIS GRONINGEN1
BIOCOMPUTING PLATFORMS LTD OY1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CIAOTECH1
CRITICAL PATH INSTITUTE STICHTING1
ELEVATE BV1
EURORDIS EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION1
FACULDADE DE FARMACIA DA UNIVERSIDADE DE LISBOA1
HELSINGIN JA UUDENMAAN SAIRAANHOITOPIIRIN KUNTAYHTYMAE1
INSTITUTO PORTUGUES DE ONCOLOGIA DO PORTO FRANCISCO GENTIL EPE1
ISTITUTO ROMAGNOLO PER LO STUDIO DEI TUMORI DINO AMADORI IRST1
KAROLINSKA INSTITUTE1
QUINTEN1
REGION HOVEDSTADEN1
SIEMENS1
STICHTING DUTCH INSTITUTE FOR CLINICAL AUDITING1
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS1
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM1
THE EUROPEAN MULTIPLE SCLEROSIS PLATFORM AISBL1
TTOPSTART BV1
UNIVERSITA CATTOLICA DEL SACRO CUORE1
UNIVERSITE PARIS CITE1
UPPSALA UNIVERSITET1

Constancy:

Total number of partners: 23
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 23
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2023-01-01More Effectively Using Registries to suppOrt PAtient-centered Regulatory and HTA decision-making More-EUROPAparticipant6.997.52314
2022-12-01Implementing value-based oncology care at European cancer hospitals: An AI-based framework for assessing real-life effectiveness of novel cancer therapies in real-time ONCOVALUEparticipant6.953.00411